Market Place
Sourcing Support
Standigm named as a Tech Innovator in Generative AI in Drug Discovery use case
19 Dec 2023 //
PR NEWSWIRE
Standigm and Nashville Biosciences join to revolutionize early drug discovery
10 Aug 2023 //
PR NEWSWIRE
Standigm announces Younsung Choo as chief executive officer
12 Apr 2023 //
PR NEWSWIRE
Standigm Synthetic Research Centre accelerates drug discovery in its first year
18 Nov 2022 //
PHARMABIZ
Standigm Synthetic Research Center successfully accelerates drug discovery
16 Nov 2022 //
PRNEWSWIRE
Standigm To Attend Bio-Europe® 2022
18 Oct 2022 //
PRNEWSWIRE
Standigm names Carl Foster CBO to expand strategic partnerships for AI drug
18 Aug 2022 //
PRNEWSWIRE
Standigm Signs MOU with Merck Korea for AI drug Discovery Research
01 Jun 2022 //
PRNEWSWIRE
Standigm Establishes Synthetic Research Center to Improve AI Drug Discovery
08 Nov 2021 //
PRNEWSWIRE
Korean AI drug discovery company expands global footprints with new office at UK
20 Aug 2021 //
BIOSPECTRUM ASIA
Korean startup Standigm to open synthetic research centre for drug development
09 Jul 2021 //
BIOSPECTRUMASIA
Korean startup Standigm to open synthetic research centre for drug development
05 Jul 2021 //
BIOSPECTRUMASIA
Standigm Secures Strategic Investment from SK Chemicals
02 Jul 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.